We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
featured
Published in Urology

Journal Scan / Research · February 03, 2020

Multiparametric Magnetic Resonance Imaging as a Noninvasive Assessment of Tumor Response to Neoadjuvant Pembrolizumab in Muscle-Invasive Bladder Cancer

European Urology

 

Additional Info

Disclosure statements are available on the authors' profiles:

European Urology
Multiparametric Magnetic Resonance Imaging as a Noninvasive Assessment of Tumor Response to Neoadjuvant Pembrolizumab in Muscle-Invasive Bladder Cancer: Preliminary Findings From the PURE-01 Study
Eur Urol 2019 Dec 24;[EPub Ahead of Print], A Necchi, M Bandini, G Calareso, D Raggi, F Pederzoli, E Farè, M Colecchia, L Marandino, M Bianchi, A Gallina, R Colombo, N Fossati, G Gandaglia, U Capitanio, F Dehò, P Giannatempo, R Lucianò, A Salonia, R Madison, SM Ali, JH Chung, JS Ross, A Briganti, F Montorsi, F De Cobelli, A Messina

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading